SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $397,000 | -20.6% | 22,844 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $500,000 | +14.4% | 22,844 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $437,000 | +45.2% | 22,844 | +30.2% | 0.00% | +100.0% |
| Q2 2021 | $301,000 | +32.6% | 17,544 | +14.0% | 0.00% | 0.0% |
| Q3 2020 | $227,000 | -68.7% | 15,392 | -68.6% | 0.00% | -66.7% |
| Q2 2020 | $726,000 | +122.7% | 49,020 | +64.9% | 0.00% | +50.0% |
| Q1 2020 | $326,000 | -33.7% | 29,720 | -57.6% | 0.00% | -33.3% |
| Q2 2018 | $492,000 | +163.1% | 70,140 | +433.3% | 0.00% | +200.0% |
| Q1 2018 | $187,000 | -58.5% | 13,152 | -74.4% | 0.00% | -50.0% |
| Q4 2017 | $451,000 | +176.7% | 51,439 | +270.3% | 0.00% | +100.0% |
| Q3 2017 | $163,000 | – | 13,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
| Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
| Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
| Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
| Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
| Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
| DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
| COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
| Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |